Eli Lilly (LLY) removes 1.625% Notes Due 2026 from NYSE listing

Rhea-AI Filing Summary

Eli Lilly & Co filed a Form 25 via the New York Stock Exchange to remove its 1.625% Notes Due 2026 from listing and registration. The Exchange certified compliance with 17 CFR 240.12d2-2 and the issuer confirmed voluntary withdrawal procedures. The notice is signed by Tyler Mastronardi of Market Watch.

Key Figures

Commission File Number: 001-06351 Coupon and maturity: 1.625% Notes Due 2026 Cited rule: 17 CFR 240.12d2-2 +1 more

4 metrics

Commission File Number 001-06351 Form 25 cover data

Coupon and maturity 1.625% Notes Due 2026 Class of securities being removed

Cited rule 17 CFR 240.12d2-2 Exchange compliance citation

Form expiry stamp March 31, 2018 document header expiry date

Key Terms

Form 25, withdrawal from listing, 17 CFR 240.12d2-2

3 terms

Form 25 regulatory

"FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION"

A Form 25 is an official filing with the U.S. Securities and Exchange Commission used to remove a company's stock or other security from a national exchange list. Investors should care because delisting often means less visibility, lower trading volume and wider price swings—similar to a product moving from a major supermarket to a small local market, which can make buying, selling and valuing the security more difficult.

withdrawal from listing regulatory

"voluntary withdrawal of the class of securities from listing and registration"

17 CFR 240.12d2-2 regulatory

"Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules"

A U.S. Securities and Exchange Commission rule that describes the conditions and procedural steps for a security to be removed from public registration or reporting under the Securities Exchange Act of 1934. For investors, it matters because it explains when a company’s shares can stop being subject to regular disclosure and exchange listing rules — similar to knowing when a publicly tracked product will be discontinued and no longer send updates, which affects transparency and liquidity.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-06351

Issuer:	ELI LILLY & Co
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	Lilly Corporate Center
	Indianapolis	INDIANA	46285
Telephone number:					(317) 276-2000

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

1.625% Notes Due 2026

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-06-02	By	Tyler Mastronardi		Analyst, Market Watch
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Eli Lilly's (LLY) Form 25 mean?

It notifies the Exchange and SEC that a class of securities will be removed from listing. The Form 25 here applies to the 1.625% Notes Due 2026 and states the Exchange and issuer complied with the cited rules for voluntary withdrawal.

Which security is being removed for LLY?

The affected class is the 1.625% Notes Due 2026. The filing identifies that note series by coupon and maturity and directs removal of that class from NYSE listing and registration.

Who certified the removal on behalf of the Exchange?

The New York Stock Exchange certified the Form 25 filing. The notice is signed by Tyler Mastronardi, Analyst, Market Watch, representing the Exchange's compliance with 17 CFR 240.12d2-2.

Is this a compulsory delisting or voluntary withdrawal for LLY?

The filing states the issuer complied with Exchange rules governing voluntary withdrawal. It cites sections of 17 CFR 240.12d2-2 and confirms the Exchange followed strike/withdrawal procedures.

Does the Form 25 disclose investor remedies or next steps?

The Form 25 itself reports removal/withdrawal procedures and compliance. It does not provide settlement terms or investor instructions; subsequent disclosures or notices would carry procedural details.